[FATE] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
08-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 14.38%
YoY- 44.05%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 6,772 1,925 1,676 1,944 933 58,980 44,356 -71.46%
PBT -38,427 -48,004 -44,122 -45,170 -52,755 -18,881 -56,363 -22.55%
Tax 0 4,778 18,832 -4,740 -4,381 -9,711 -8,056 -
NP -38,427 -48,004 -44,122 -45,170 -52,755 -9,170 -48,307 -14.15%
Tax Rate - - - - - - - -
Total Cost 45,199 49,929 45,798 47,114 53,688 68,150 92,663 -38.06%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -567.44 -2,493.71 -2,632.58 -2,323.56 -5,654.34 -15.55 -108.91 200.84%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.33 -0.47 -0.45 -0.46 -0.54 -0.09 -0.50 -24.21%
EPS Diluted -0.33 -0.47 -0.45 -0.46 -0.54 -0.09 -0.50 -24.21%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.